Form 4: MRC Global Executive Kelly Youngblood Receives Restricted Stock Units
SEC Form 4 Filing
Kelly Youngblood, Executive Vice President and CFO of MRC Global, was granted 50,608 Restricted Stock Units on March 12, 2025.
Summary
- On March 12, 2025, Kelly Youngblood, Executive Vice President and CFO of MRC Global, received 50,608 Restricted Stock Units.
- Each Restricted Stock Unit represents a contingent right to receive one share of MRC Global's Common Stock.
- 34% of the grant will vest on March 12, 2026, and 33% will vest on each of March 12, 2027, and March 12, 2028.
- Vesting is contingent upon continued service with the issuer and may be accelerated under certain circumstances.
- Following the transaction, Youngblood directly owns 280,073 shares of MRC Global Common Stock.
Sentiment
Score: 7
Explanation: The document indicates standard executive compensation practices, which is generally viewed neutrally to positively as it aligns management with shareholder interests.
Positives
- The grant of Restricted Stock Units aligns the executive's interests with those of the shareholders, incentivizing continued service and performance.
Risks
- The value of the Restricted Stock Units is subject to the performance of MRC Global's stock price.
- Vesting is contingent upon continued service, so any departure from the company would result in forfeiture of unvested units.
Future Outlook
The executive's compensation is tied to the company's stock performance, suggesting a focus on long-term value creation.
Industry Context
Grants of restricted stock units are a common form of executive compensation in publicly traded companies, aligning management's interests with those of shareholders.
Stakeholder Impact
- Shareholders may view the grant positively as it incentivizes management to improve company performance.
- Employees may see the grant as a sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 03/12/2025 | Date of the Restricted Stock Unit grant |
| 03/12/2026 | First vesting date (34%) |
| 03/12/2027 | Second vesting date (33%) |
| 03/12/2028 | Third vesting date (33%) |
| 03/14/2025 | Date of Form 4 signature |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.